女性健康设备市场－2026-2031年预测

预计女性健康设备市场将从 2025 年的 407.74 亿美元成长到 2031 年的 644.34 亿美元，复合年增长率为 7.92%。

女性健康设备市场透过先进的诊断和监测技术，应对日益增多的乳癌和卵巢癌病例。旨在改善健康状况的全球宣传宣传活动和教育措施正在推动市场成长。此外，该市场也致力于解决老年女性罹患慢性病和生殖系统疾病的风险日益增加的问题。针对女性特定医疗保健解决方案的大量投资和创新正在推动该市场的进一步发展。

女性健康设备旨在诊断、监测和治疗女性特有或常见的疾病，例如乳癌和卵巢癌等妇科疾病。这些疾病发生率的上升趋势，以及女性人口的成长和健康意识的提高，是推动该市场成长要素。

成长要素是女性特有的各种健康问题的日益增加。女性面临不成比例的风险，包括性健康和生殖健康的併发症。例如，根据世界卫生组织2023年的报告，在实行女性生殖器切割（FGM）的地区，将有超过2亿女孩和妇女遭受这种残害。

乳癌和卵巢癌发生率的不断上升显着推动了对相关设备的需求。根据世界癌症研究基金会（WCRF）统计，卵巢癌是全球女性第八大常见癌症。这些恶性肿瘤凸显了专业诊断和筛检设备在早期发现和治疗中的重要性。

老年女性人口的不断增长也是推动市场发展的重要因素，因为她们更容易罹患糖尿病和卵巢癌等疾病。根据美国国家生物技术资讯中心（NCBI）估计，到2025年，全球老年女性人口预计将达到约6.04亿，这将进一步增加对标靶医疗设备的需求。

多项宣传活动正在促进女性健康素养的提升和医疗器材的普及。由北卡罗来纳州人类研究与社区参​​与办公室 (OHRCE)、临床研究委员会 (CRB) 和国家环境健康科学研究所 (NIEHS) 等机构主导的北卡罗来纳州女性健康意识 (WHA) 社区参与项目，就是一个推进研究和提高公众意识的良好范例。

鑑于上述成长要素，市场准入和扩张的机会巨大。世界经济论坛在2023年1月指出，对女性专案研究进行约3亿美元的重点投资，可透过降低医疗成本、提高生活品质和提升劳动生产力，创造130亿美元的经济回报。政府措施、宣传宣传活动和以投资为重点的会议预计将对该领域产生积极影响。

从地理上看，由于乳癌高发生，预计北美将在预测期内占据显着的市场份额。根据美国癌症协会统计，乳癌占美国女性新发癌症病例的30%，预计2023年新增侵袭性乳癌病例将达297,790例。女性劳动参与率的提高以及相对于男性收入的成长，推动了个人医疗保健支出的增加，进而促进了医疗设备的使用。

女性健康医疗器材领域的主要企业包括GE医疗集团，这是一家全球领先的医药诊断、数位化解决方案和医疗技术供应商。该公司旗下的Voluson®女性健康超音波产品线涵盖了许多先进系统，例如具备先进影像功能的Voluson® Expert系列，以及专为产科、妇科和辅助生殖技术设计的Voluson® Performance。总部位于美国的女性健康医疗器材专家Caldera Medical致力于透过其产品提升​​医疗照护标准，例如用于治疗压力性尿失禁的Desara®系统、用于骶骨阴道固定术的Vertessa®系统以及用于治疗难治性宫底和角膜组织穿刺的Benesta®系统。 Hologic是女性健康领域的知名企业，专注于乳房、妇科、性健康、身体组成和骨骼健康，并提供诸如3Dimensions®乳房X光摄影系统和用于改善乳房健康筛检的3DQuorum™成像技术等解决方案。

总体而言，在人口结构变化、疾病负担、宣传活动以及针对女性医疗保健领域未满足需求的创新措施的推动下，市场预计将稳定成长。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章：女性健康设备市场（依应用领域划分）

• 介绍
• 癌症
• 骨质疏鬆症
• 感染疾病
• 子宫肌瘤
• 停经后症候群
• 怀孕
• 女性节育手术
• 其他的

6. 按最终用户分類的女性健康设备市场

• 介绍
• 医院
• 妇产科诊所
• 诊断检查室
• 门诊手术中心

7. 按地区分類的女性健康设备市场

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第八章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第九章：公司简介

• Abbott Laboratories
• GE Healthcare
• Caldera Medical
• MedGyn Products
• F. Hoffmann-La Roche
• Hologic
• Koninklijke Philips
• Siemens AG

第十章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

The women's health devices market, with a 7.92% CAGR, is anticipated to reach USD 64.434 billion in 2031 from USD 40.774 billion in 2025.

The women's health devices market is addressing escalating cases of breast and ovarian cancer through advanced diagnostic and monitoring technologies. Growth is supported by global awareness campaigns and educational initiatives aimed at improving health outcomes. The market is also catering to an aging female population with heightened vulnerability to chronic and reproductive conditions. Significant investments and innovations targeted at female-specific healthcare solutions are driving further advancement.

Women's health devices are specifically engineered to diagnose, monitor, and treat conditions unique to or predominant in women, including breast and ovarian cancers as well as broader gynecologic health issues. The rising prevalence of these illnesses, combined with an expanding female population and heightened health awareness, constitutes primary growth drivers for the market.

Key growth factors include the multitude of women-associated health concerns with elevated incidence rates. Women face disproportionate risks in areas such as sexual and reproductive health complications. For instance, more than 200 million girls and women worldwide have undergone female genital mutilation (FGM) in practicing regions as reported by the WHO in 2023.

The increasing prevalence of breast and ovarian cancers significantly augments demand. Ovarian cancer ranks as the 8th most common cancer in women globally according to the World Cancer Research Fund (WCRF). These malignancies underscore the critical role of specialized diagnostic and screening devices in early detection and management.

An expanding elderly female population further propels the market, as older women are more susceptible to conditions like diabetes and ovarian cancer. Projections indicate approximately 604 million elderly women worldwide by 2025 per NCBI estimates, amplifying the need for targeted health devices.

Multiple awareness programs enhance women's health literacy and device adoption. Initiatives led by organizations such as the Office of Human Research and Community Engagement (OHRCE), Clinical Research Branch (CRB), and National Institute of Environmental Health Sciences (NIEHS) through the Women's Health Awareness (WHA) Community Engagement Programme in North Carolina exemplify efforts to promote research and advocacy.

Opportunities for market entry and expansion are substantial, driven by the aforementioned growth factors. Recognition at the World Economic Forum in January 2023 highlighted that targeted investments of around $300 million in women-specific research could yield $13 billion in economic returns through healthcare savings, improved quality of life, and enhanced workforce productivity. Government efforts, awareness campaigns, and investment-focused conferences are expected to positively influence the sector.

Geographically, North America is projected to secure a significant market share during the forecast period. Contributing elements include high breast cancer incidence, with the disease accounting for 30% of all new female cancer cases in the US according to the American Cancer Society, and approximately 297,790 new invasive cases estimated in 2023. Rising female workforce participation and increasing earnings relative to men enable greater personal health expenditure, further bolstering device uptake.

Leading companies in the women's health devices arena include GE Healthcare, a global provider of pharmaceutical diagnostics, digital solutions, and medical technology. The company's Voluson Women's Health Ultrasound portfolio spans advanced systems like the Voluson(TM) Expert Series for progressive imaging capabilities and Voluson(TM) Performance tailored for obstetrics, gynecology, and assisted reproductive medicine. Caldera Medical, a US-based specialist in women's health devices, focuses on elevating standards of care with products such as Desara(R) for stress urinary incontinence, Vertessa(R) for sacrocolpopexy procedures, and the Benesta(R) System for accessing challenging fundal and corneal tissue. Hologic, a prominent women's health company, emphasizes breast, gynecologic, sexual, body composition, and skeletal health, offering solutions like the 3Dimensions(R) Mammography System and 3DQuorum(TM) Imaging Technology for enhanced breast health diagnostics.

Overall, the market is poised for steady growth, fueled by demographic shifts, disease burden, awareness initiatives, and targeted innovations that address unmet needs in female-specific healthcare.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Women's Health Devices Market Segmentation

• By Application
• Cancer
• Osteoporosis
• Infectious Disease
• Uterine Fibroids
• Post-menopausal Syndrome
• Pregnancy
• Female Sterilization
• Other
• By End-User
• Hospitals
• Obstetrics & Gynecology Clinics
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WOMEN'S HEALTH DEVICES MARKET BY APPLICATION

• 5.1. Introduction
• 5.2. Cancer
• 5.3. Osteoporosis
• 5.4. Infectious Disease
• 5.5. Uterine Fibroids
• 5.6. Post-menopausal Syndrome
• 5.7. Pregnancy
• 5.8. Female Sterilization
• 5.9. Other

6. WOMEN'S HEALTH DEVICES MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals
• 6.3. Obstetrics & Gynecology Clinics
• 6.4. Diagnostic Laboratories
• 6.5. Ambulatory Surgical Centers

7. WOMEN'S HEALTH DEVICES MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. Abbott Laboratories
• 9.2. GE Healthcare
• 9.3. Caldera Medical
• 9.4. MedGyn Products
• 9.5. F. Hoffmann-La Roche
• 9.6. Hologic
• 9.7. Koninklijke Philips
• 9.8. Siemens AG

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key Benefits for the Stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations